Waning covid tells on health of Divi Labs stock
- Divi Laboratories had a stellar run over the past two years, aided by capacity expansion and covid projects.
The stock of Divi’s Laboratories Ltd has lost its charm this year. The stock fell by nearly 9% on Monday after the company’s September quarter (Q2FY23) results fell far short of the Street’s expectations. Tuesday was a stock market holiday because of Guru Nanak Jayanti. The stock has lost 27% so far in CY22, more than wiping out the gains seen in CY21.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more